骨密度计:一个更新.

Same author

Does 18F-sodium fluoride PET/CT have a role in the assessment of response to 223Ra therapy in men with prostatic bone metastases?

European journal of nuclear medicine and molecular imaging·2026

Same author

An evaluation of dual-layer detector spectral CT for the estimation of MRI proton density fat fraction of the liver.

Quantitative imaging in medicine and surgery·2026

Same author

Automated CT-Based Muscle Density Predicts Mortality Regardless of Muscle Area.

Journal of cachexia, sarcopenia and muscle·2026

Same author

Automated CT-based visceral fat density predicts mortality regardless of visceral fat area.

The British journal of radiology·2026

Same author

Epidemiology of brachydactyly type A3 in China: a nationwide multicentre population-based study among children aged 3-17 years.

BMJ open·2025

Same author

Focal bone defects in type 2 diabetes mellitus patients with acute hip fractures.

Quantitative imaging in medicine and surgery·2025

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

骨密度计:一个更新.

相关概念视频

Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?

An evaluation of dual-layer detector spectral CT for the estimation of MRI proton density fat fraction of the liver.

Automated CT-Based Muscle Density Predicts Mortality Regardless of Muscle Area.

Automated CT-based visceral fat density predicts mortality regardless of visceral fat area.

Epidemiology of brachydactyly type A3 in China: a nationwide multicentre population-based study among children aged 3-17 years.

Focal bone defects in type 2 diabetes mellitus patients with acute hip fractures.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

骨密度计:一个更新.

相关概念视频

相关文章

Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?

An evaluation of dual-layer detector spectral CT for the estimation of MRI proton density fat fraction of the liver.

Automated CT-Based Muscle Density Predicts Mortality Regardless of Muscle Area.

Automated CT-based visceral fat density predicts mortality regardless of visceral fat area.

Epidemiology of brachydactyly type A3 in China: a nationwide multicentre population-based study among children aged 3-17 years.

Focal bone defects in type 2 diabetes mellitus patients with acute hip fractures.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.